Publication: Factores relacionados con la presencia de infección o colonización por pseudomonas aeruginosa y acinetobacter baumannii resistentes a carbapenemes en unidad de cuidado intensivo uci en instituciones de Bogotá 2004-2006.
| dc.contributor.author | Saavedra Trujillo, Carlos | |
| dc.contributor.author | Leal, Aura Lucía | |
| dc.contributor.author | Eslava Schmalbach, Javier | |
| dc.contributor.author | Cuervo, Sonia Isabel | |
| dc.contributor.author | Murcia, Martha | |
| dc.contributor.author | Gualtero, Sandra Milena | |
| dc.contributor.author | Arias, León Gerson | |
| dc.contributor.author | Villegas, María Virginia | |
| dc.contributor.author | Correa, Adriana | |
| dc.date.accessioned | 2023-12-14T19:09:57Z | |
| dc.date.available | 2023-12-14T19:09:57Z | |
| dc.date.issued | 2006 | |
| dc.description | 1 documento | |
| dc.description.abstract | Los pacientes muy enfermos deben hospitalizarse en unas salas de atención especiales que se denominan unidades de cuidados intensivos (UCI) es indudable que la posibilidad de ingresar en una UCI permite la supervivencia de muchas personas que de otra forma estarían condenadas a la muerte. Sin embargo debido a las condiciones propias de la gravedad clínica y la necesidad de realizar múltiples formas de terapia invasiva, muchos pacientes presentan complicaciones e tipo infeccioso que de poderse prevenir mejorarían su pronóstico. En la actualidad hay dos gérmenes causantes de infección dentro de las UCI que afectan de forma significativa ·!as posibilidades de vida de este grupo de pacientes. Este es un estudio que pretende conocer el comportamiento de estos gérmenes y descifrar las razones para su aparición y su agresividad, a partir de su diferenciación entre resistentes o sensibles a los antibióticos mas reconocidos para su tratamiento, los carbapenemes, y así poder proponer medidas de control que resulten en un mejor de los enfermos que ingresan a UCI. | spa |
| dc.format.extent | 183 p. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.uri | https://repositorio.minciencias.gov.co/handle/20.500.14143/50038 | |
| dc.language.iso | spa | |
| dc.publisher | Universidad Nacional de Colombia | |
| dc.publisher | Colciencias | |
| dc.publisher.place | Bogotá | |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess | |
| dc.rights.creativecommons | Atribución 4.0 Internacional (CC BY 4.0) | |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
| dc.subject.lemb | Proyectos de investigación | |
| dc.subject.lemb | Investigación científica | |
| dc.subject.lemb | Infecciones | |
| dc.subject.proposal | Unidades de cuidados intensivos | |
| dc.title | Factores relacionados con la presencia de infección o colonización por pseudomonas aeruginosa y acinetobacter baumannii resistentes a carbapenemes en unidad de cuidado intensivo uci en instituciones de Bogotá 2004-2006. | spa |
| dc.type | Informe de investigación | |
| dc.type.coar | http://purl.org/coar/resource_type/c_18ws | |
| dc.type.content | Text | |
| dc.type.driver | info:eu-repo/semantics/report | |
| dc.type.redcol | http://purl.org/redcol/resource_type/INF | |
| dc.type.version | info:eu-repo/semantics/publishedVersion | |
| dcterms.audience | Estudiantes, Profesores, Comunidad científica colombiana, etc., | spa |
| dcterms.references | Yetkin G, Otlu 8, Cicek A, Kuzucu C, Durmaz R. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey. Am J lnfect Control 2006; 34: 188-92. | |
| dcterms.references | Instituto Nacional de Cancerología: Anuario Estadístico 2004. República de Colombia, Ministerio de la Protección Social. 2005. P.73. | |
| dcterms.references | Corona- Nakamura AL, Miranda - Novales MG, Leaños-Miranda B, PortilloGómez L, Hernández-Chávez A, Anthor- Rendón J, et al. Epidemiologic study of Pseudomonas aeruginosa in critica! patients and reservoirs. Arch MedRes 2001 ; 32: 238-42. | |
| dcterms.references | Thuong M, Arvaniti K, Ruimy R, De la Salmoniére P, Scanvic- Hameg A, Lucet J.C, et al. Epidemiology of Pseudomonas aeruginosa and risk factors for carriage acquisition in an intensive care unit. J Hosp lnfect 2003; 53: 274-82 | |
| dcterms.references | Thuong M, Arvaniti K, Ruimy R, De la Salmoniére P, Scanvic- Hameg A, Lucet J.C, et al. Epidemiology of Pseudomonas aeruginosa and risk factors for carriage acquisition in an intensive care unit. J Hosp lnfect 2003; 53: 274-82 | |
| dcterms.references | Livermore D. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin lnfect Dis 2002; 34: 634-40. | |
| dcterms.references | Gómez Álvarez CA, Leal Castro AL, Pérez de González MJ, Navarrete Jiménez ML. Mecanismos de resistencia en Pseudomonas aeruginosa: entendiendo a un peligroso enemigo . Rev Fac Med Univ Nac Colomb 2005; 53 : 27-34 | |
| dcterms.references | Streit JM , Jones RN , Sader HS , Fritsche TR. Assessment of pathogen occurrences and resistance profiles in the intensive care unit: report from the SENTRY antimicrobial surveillance program (North America , 2001 ). lnt J Antimicrob Agents 2004; 24 : 111-8 .. | |
| dcterms.references | Hanberger H, Erlandsson M , Burman LG , Cars O , Gill H, Lindgren S , et al. High antibiotic susceptibility among bacteria! pathogens in swedish ICUs. Scand J lnfect Oís 2004 ; 36 : 24-30. | |
| dcterms.references | Hanberger H, Erlandsson M , Burman LG , Cars O , Gill H, Lindgren S , et al. High antibiotic susceptibility among bacteria! pathogens in swedish ICUs. Scand J lnfect Oís 2004 ; 36 : 24-30. | |
| dcterms.references | Boffi El Amari E, Chamot E, Auckenthaler R, Pechér e JC , Van Delden C. lnfluence of previous exposure to antibiotic therapy on the susceptibility pattern of Pseudomonas aeruginosa bacteremic isolates. Clin lnfect Oís 2001 ; 33 : 1859-64 | |
| dcterms.references | Mendes C , Oplustil C , Sakagami E, Turner P, Kiffer C, and the MYSTIC Brazil Group. Antimicrobial susceptibility in intensive care units : MYSTIC program Brazil 2002 . Braz J lnfect Oís 2005 ; 9: 44-51 | |
| dcterms.references | Áivarez e, Cortes J, Arango A Correa C , Leal A , Greba . Resistencia antimicrobiana en unidades de cuidado intensivo de Bogotá , Colombia , 2001-2003. Rev Salud Pública 2006 ; Sup 8: 86-101 . | |
| dcterms.references | Garner JS , Jarvis WR, Horan TC , Hughes JM . CDC definitions for nosocomial infections , in : Olmsted RN . Ed : APIC infection control and applied epidemiology ; Principies and practice . 1996. St Louis ; A-1-20. | |
| dcterms.references | Edgeworth J, Treacher D, Eykyn S. A 25- year study of nosocomial bacteremia in an adult intensive care unit. Crit Care Med 1999; 27: 1421 -8. | |
| dcterms.references | Sligl W, Taylor G, Brindley P. Five years of nosocomial Gram-negative bacteremia in a general intensive care unit: epidemiology, antimicrobial susceptibility patterns, and outcomes. lnt J lnfect Ois 2006; 10: 320-25. | |
| dcterms.references | Rhomberg PR, Jones RN. Contemporary activity of meropenem and comparator broad-spectrum agents: MYSTIC program report from the United States component (2005). Oiagn Microbiollnfect Dis 2007; 57: 207- 15. | |
| dcterms.references | Pascual A, Perea E, Alvarez M, Casal M, Garcia de Lomas J, García Rodríguez JA, et al. The meropenem yearly susceptibility test information collection antimicrobial susceptibility program in Spain: a 5 year analysis. Diagn Microbiollnfect Dis 2007; 57: 195-200. | |
| dcterms.references | Crespo MP, Woodford N, Sinclair A, Kaufmann ME, Turton J, Glover J, et al. Outbreak of carbapenem - resistant Pseudomonas aeruginosa producing VIM-8, a novel metallo-beta-lactamase, in a tertiary care center in Cali, Colombia. J Clin Microbio! 2004; 42: 5094-101 . | |
| dcterms.references | Kriengkauykiat J, Porter E, Lomovskaya O, Wong- Beringer A. Use of an efflux pump- mediated fluoroquinolone resistance and multidrug resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother therapy 2005; 49: 565-70. | |
| dcterms.references | Livermore D M, Winstanley T G, Shannon K P. lnterpretative reading_: recognizing the unusual and inferring resistance mechanisms from resistance phenotypes. J Antimicrob Chemother2001 ; 48 S1 : 87-102 | |
| dcterms.references | Poole K. Aminoglycoside resistance in Pseudomonas aeruginosa . Antimicrob Agents Chemother. 2005 ; 49 : 479-87 . | |
| dcterms.references | Paul M , Benury-Silbinger 1, Soares-Weiser K, Leibovici L. ~- Lactam monotherapy versus o lactam - aminoglycoside combination therapy for sepsis in immunocompetent patients : systematic review and meta - analysis of randomised trials . BMJ, doi: 1 0.1136/bmj .38028.520995.63 | |
| dcterms.references | Paul M , Benury-Silbinger 1, Soares-Weiser K, Leibovici L. ~- Lactam monotherapy versus o lactam - aminoglycoside combination therapy for sepsis in immunocompetent patients : systematic review and meta - analysis of randomised trials . BMJ, doi: 1 0.1136/bmj .38028.520995.63 | |
| dcterms.references | idal F , Mensa J , AlmelaM , Martínez JA, Marco F , Casals C . Epidemiology and outcome of Pseudomonas aeruginosa bacteremia , with special emphasis on the influence of antibiotic treatment. Analysis of 189 episodes. Arch lntern Med 1996; 156: 2121 -6 | |
| dcterms.references | Osmon S , Ward S , Fraser V , Koleff M. Hospital morality for patients with bacteremia due to Staphylococcus aureus or Pseudomonas aeruginosa . Chest 2004 ; 125: 607-16 | |
| dcterms.references | Kollef MH , Sherman G , Ward S , Fraser VJ . lnadequate antimicrobial treatment of infections : a risk factor for hospital mortality among critically ill patients . Chest 1999; 115: 462-74 . | |
| dcterms.references | Kollef MH , Ward S . The influence of mini - BAL cultures on patient outcomes : implications for the antibiotic ma nagement of ventilatorassociated pneumonia . Chest 1998; 113 : 412-20. | |
| dcterms.references | Doern G, Vautour R, Gaudet M, Levy B . Clinical impact of rapid in vitre susceptibility testing and bacteria! identification . J Clin Microbio! 1994; 32 : 1757-62. | |
| dcterms.references | Doern G, Vautour R, Gaudet M, Levy B . Clinical impact of rapid in vitre susceptibility testing and bacteria! identification . J Clin Microbio! 1994; 32 : 1757-62. | |
| dcterms.references | Barenfanger J , Drake C , Kacich G . Clinical and beneficia! benefits of rapid bacteria! identification and antimicrobial susceptibility testing . J C!in Microbio! 1999; 37 : 1415-18 . | |
| dcterms.references | 1brahim E, Sherman G , Ward S , Fraser V , Kollef M . The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting . Chest 2000 ; 118 :146-55 | |
| dcterms.references | Cheol-ln K , Sung-Han K, Hong -Bin K, Sang-Wong P, Young-Ju C, MyoungDon Oh , et al. Pseudomonas aeruginosa bacteremia : risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. Clin lnfect Dis 2003 ; 37 : 745-51 . | |
| dcterms.references | Micek S , Lloyd A , Ritchie D, Reichley R , Fraser V , Kollef M. Pseudomonas aerug inosa bloodstream infection : importance of appropriate initial antimicrobial treatment. Antimicrob Agents Chemother 2005 ; 49: 1306-11 | |
| dcterms.references | . García P. Ventajas y problemas de los métodos automatizados de estudio de susceptibilidad in vitre. Rev Chillnfect 2002; 19: 96-1 OO . | |
| dcterms.references | Biedenbach D, Jones R. lnterpretive errors using an automated system for the susceptibility testing of lmipenem and Aztreonam . Diagn Microbiollnfect Dis. 1995; 21:57-60 . | |
| dcterms.references | Sanders C , Peyret M , Molland E , Shubert C , Thomson K, Boeufgras J, et al. Ability of the VI TEK 2 advanced expert system to identify ¡3-Lactam phenotypes in isolates of Enterobacteriaceae and Pseudomonas aeruginosa . J Clin Microbio/ 2000 ; 38 : 570-4. | |
| dcterms.references | Ling T , Tam P, Liu Z , Cheng A. Evaluation of VITEK 2 rapid identification and susceptibility testing system against Gram negative clinical isolates. J Clin Microbio/2001 ; 39: 2964-6 . | |
| dcterms.references | Buns J , Saiman L , Whittier S , Krzewinski J , Liu Z , Larona D, et al. Comparison of two commercial systems (Vitek and MicroScan-WalkAway System) for antimicrobial susceptibil ity testing of Pseudomonas aeruginosa isolates from cystic fibrosis patients. Diagn Microbiollnfect Dis 2001 ; 39 : 257-60 . | |
| dcterms.references | Buns J , Saiman L , Whittier S , Krzewinski J , Liu Z , Larona D, et al. Comparison of two commercial systems (Vitek and MicroScan-WalkAway System) for antimicrobial susceptibil ity testing of Pseudomonas aeruginosa isolates from cystic fibrosis patients. Diagn Microbiollnfect Dis 2001 ; 39 : 257-60 . | |
| dcterms.references | Jayanes P , Conejo M, Martínez L , Perea E. Evaluation of the VI TEK 2 system for the identification and susceptibility testing of three species of nonfermenting Gram-negative rods frequently isolated from clinical samples . J Clin Microbio/2001 ; 39 : 3247-53 . | |
| dcterms.references | Steward C , Mohammed J , Swenson J , Stocker S , Williams P, Gaynes R, et al. Antimicrobial susceptibility testing of carbapenems : multicenter validity testing and accuracy level of five antimicrobial test methods for detecting resistance in Enterobacteriaceae and Pseudomonas aeruginosa isolates. J Clin Microbio! 2003 ; 41 : 351-8 . | |
| dcterms.references | Sader H , Fritsche T , Jones R. Accuracy of three automated systems (MicroScan WalkAway , VITEK, and VITEK 2) for susceptibility testing of Pseudomonas aeruginosa against five broad-spectrum beta-lactam agents. J Clín Mícrobío/2006 ; 44: 1101-4. | |
| dcterms.references | Jones R , Biedenbach D , Marshall S , Pfaller M , Doern G . Evaluation of the Vitek system to accurately test the susceptibility of Pseudomonas aeruginosa clinical isolates against Cefepime . Diagn Microbiollnfect Dis 1998; 32 : 107-10. | |
| dcterms.references | Biedenbach J, Marshall S, Jones R. Accuracy of Cefepime antimicrobial susceptibility testing results for Pseudomonas aeruginosa tested on the MicroScan WalkAway system. Diagn Microbiollnfect Oís 1999; 33: 305-7. 44. Karlowsky J, Weaver M, Thornsberry C, Dowzicky M, Jones M, Sahm D. | |
| dcterms.references | Karlowsky J, Weaver M, Thornsberry C, Dowzicky M, Jones M, Sahm D. Comparison of four antimicrobial susceptibility testing methods to determine the in-vitro activities of Piperacillin and Piperacillin-Tazobactam against clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa. J Clin Microbio! 2003; 41 : 3339-43. | |
| dcterms.references | Brown D.F.J and L. Brown. Evaluation of the E test, a novel method of quantifying antimicrobial activity. J Antimicrob Chemother 1991 ; 27: 185-90 | |
| dcterms.references | Di Bonaventura G, Ricci E, Delia Loggia N, Catamo G, Piccolomini R. Evaluation of the E Test for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from patients with long - term bladder catheterization. J Clin Microbio/1998; 36: 824-6 | |
| dcterms.references | Joyce L.F, Downes J, Stockman K, Andrew H. Comparison of five methods, including the PDM epsilometer test (E Test), for antimicrobial susceptibility testing of Pseudomonas aeruginosa. J Clin Microbial 1992; 30: 2709-13. | |
| dcterms.references | Joyce L.F, Downes J, Stockman K, Andrew H. Comparison of five methods, including the PDM epsilometer test (E Test), for antimicrobial susceptibility testing of Pseudomonas aeruginosa. J Clin Microbial 1992; 30: 2709-13. | |
| dcterms.references | Chu Y W, Cheung T, Ngan JY, Kam KM. EDTA susceptibility leading to false detection of metallo-~-lactamase in Pseudomonas aeruginosa by ETest and an imipenem-EDTA disk method. Letter to the Editor. lnt. J Antimicrob. Agents 005; 26: 340-1 . 27 | |
| dcterms.references | Vi llegas MV , Lolans O, Rosario M, Suárez J , Correa A. Queenan M , Quinn JP . First detection of metallo-~-lactamases VIM-2 in Pseudomonas aeruginosa isolates from Colombia . Antimicrob Agents Chemother 2006; 50 : 226-9. | |
| dcterms.references | 54 . Quale J, Bratu S , Gupta J , and Landman D. lnterplay of Efflux System, AmpC, and OprD Expression in Carbapenem Resistance of Pseudomonas aeruginosa Clinical lsolates . Antimicrob Agents Chemother 2006; 50 : 1633- 41 . 28 | |
| dspace.entity.type | Publication | |
| oaire.accessrights | http://purl.org/coar/access_right/c_abf2 | |
| oaire.awardnumber | 11010416355 | |
| oaire.awardtitle | Bactores relacionados con la presencia de infección o colonización por pseudomonas aeruginosa y acinetobacter baumannii resistentes a carbapenemes en unidad de cuidado intensivo uci en instituciones de Bogotá 2004-2006. | |
| oaire.funderidentifier.colciencias | 11010416355 | |
| oaire.fundername | Departamento Administrativo de Ciencia, Tecnología e Innovación [CO] Colciencias | |
| oaire.version | http://purl.org/coar/version/c_970fb48d4fbd8a85 |